| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0008 |